Skip to Content

Current Oncology, Volume 29, Issue 8

2022 August - 63 articles

Cover Story: Immediate Lymphatic Reconstruction (ILR) is a promising technique to mitigate the risk of lymphedema in patients undergoing axillary (ALND) or inguinal (ILND) lymph node dissection (LND). This study was conducted to define lymphedema rates and risk factors in the context of melanoma. A retrospective chart review over 5 years identified 66 patients having undergone LND for melanoma (ALND 34, ILND 32). At a median follow-up of 29 months, 85.3% (n = 29) of patients having had an ALND did not experience lymphedema, versus 50.0% (n = 16) of ILND (p = 0.0019). On multivariate analysis, only the location of LND remained a significant predictor of lymphedema, with inguinal location identified as a potential first target for ILR. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (63)

  • Article
  • Open Access
3 Citations
3,432 Views
22 Pages

Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in Ontario

  • Shiru L. Liu,
  • Wing C. Chan,
  • Geneviève Bouchard-Fortier,
  • Stephanie Lheureux,
  • Sarah E. Ferguson and
  • Monika K. Krzyzanowska

22 August 2022

Background: First-line treatment of epithelial ovarian cancer (EOC) consists of a combination of cytoreductive surgery and platinum-based chemotherapy. Recently, targeted therapies such as bevacizumab have been shown to improve oncologic outcomes in...

  • Review
  • Open Access
35 Citations
6,968 Views
25 Pages

Cathepsin K: A Versatile Potential Biomarker and Therapeutic Target for Various Cancers

  • Die Qian,
  • Lisha He,
  • Qing Zhang,
  • Wenqing Li,
  • Dandan Tang,
  • Chunjie Wu,
  • Fei Yang,
  • Ke Li and
  • Hong Zhang

22 August 2022

Cancer, a common malignant disease, is one of the predominant causes of diseases that lead to death. Additionally, cancer is often detected in advanced stages and cannot be radically cured. Consequently, there is an urgent need for reliable and easil...

  • Article
  • Open Access
7 Citations
3,507 Views
8 Pages

Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome

  • Yasmine Kadri,
  • Michelle Phan,
  • Nadia Bambace,
  • Léa Bernard,
  • Sandra Cohen,
  • Jean-Sébastien Delisle,
  • Thomas Kiss,
  • Sylvie Lachance,
  • Denis-Claude Roy and
  • Imran Ahmad
  • + 3 authors

22 August 2022

The purpose of this retrospective study was to study the correlation between donor age (DA) and non-relapse mortality (NRM) and relapse incidence (RI) among patients treated with allogeneic hematopoietic cell transplantation (aHCT) for acute myeloid...

  • Article
  • Open Access
18 Citations
4,962 Views
13 Pages

A Qualitative Study of Patient and Healthcare Provider Perspectives on Building Multiphasic Exercise Prehabilitation into the Surgical Care Pathway for Head and Neck Cancer

  • Julia T. Daun,
  • Rosie Twomey,
  • Joseph C. Dort,
  • Lauren C. Capozzi,
  • Trafford Crump,
  • George J. Francis,
  • T. Wayne Matthews,
  • Shamir P. Chandarana,
  • Robert D. Hart and
  • S. Nicole Culos-Reed
  • + 4 authors

21 August 2022

Head and neck cancer (HNC) surgical patients experience a high symptom burden. Multiphasic exercise prehabilitation has the potential to improve patient outcomes, and to implement it into the care pathway, the perspectives of patients and healthcare...

  • Case Report
  • Open Access
3 Citations
3,406 Views
9 Pages

Metastatic SDH-Deficient GIST Diagnosed during Pregnancy: Approach to a Complex Case

  • Anas Chennouf,
  • Elie Zeidan,
  • Martin Borduas,
  • Maxime Noël-Lamy,
  • John Kremastiotis and
  • Annie Beaudoin

20 August 2022

Gastrointestinal stromal tumors (GISTs) account for 1% of GI neoplasms in adults, and epidemiological data suggest an even lower occurrence in pregnant women. The majority of GISTs are caused by KIT and PDGFRA mutations. This is not the case in women...

  • Article
  • Open Access
17 Citations
3,923 Views
14 Pages

Patient-Reported Experiences of Breast Cancer Screening, Diagnosis, and Treatment Delay, and Telemedicine Adoption during COVID-19

  • Simo Du,
  • Laura Carfang,
  • Emily Restrepo,
  • Christine Benjamin,
  • Mara M. Epstein,
  • Ricki Fairley,
  • Laura Roudebush,
  • Crystal Hertz,
  • Leah Eshraghi and
  • Erica T. Warner

20 August 2022

Purpose: To evaluate and quantify potential sociodemographic disparities in breast cancer screening, diagnosis, and treatment due to the COVID-19 pandemic, and the use of telemedicine. Methods: We fielded a 52-item web-based questionnaire from 14 May...

  • Article
  • Open Access
1 Citations
3,156 Views
18 Pages

20 August 2022

Patients with resectable esophageal cancer are recommended to undergo chemoradiotherapy before esophagectomy. A longer time to surgery (TTS) and/or time to consultation (TTC) may be associated with inferior cancer-related outcomes and heightened anxi...

  • Article
  • Open Access
10 Citations
4,065 Views
10 Pages

Safety and Feasibility of Steerable Radiofrequency Ablation in Combination with Cementoplasty for the Treatment of Large Extraspinal Bone Metastases

  • Claudio Pusceddu,
  • Davide De Francesco,
  • Nicola Ballicu,
  • Domiziana Santucci,
  • Salvatore Marsico,
  • Massimo Venturini,
  • Davide Fior,
  • Lorenzo Paolo Moramarco and
  • Eliodoro Faiella

20 August 2022

Background: Radiofrequency ablation (RFA) and cementoplasty, individually and in concert, has been adopted as palliative interventional strategies to reduce pain caused by bone metastases and prevent skeletal related events. We aim to evaluate the fe...

  • Article
  • Open Access
8 Citations
3,587 Views
16 Pages

Functional and Survival Outcomes of Patients following the Harrington Procedure for Complex Acetabular Metastatic Lesions

  • Andrea Plaud,
  • Jean Gaillard,
  • François Gouin,
  • Aurélie Le Thuaut,
  • Peggy Ageneau,
  • Juliane Berchoud,
  • Alban Fouasson-Chailloux and
  • Vincent Crenn

19 August 2022

Background: The Harrington surgical technique makes it possible to manage complex, extensive bone lesions using pins and cement to consolidate bone for acetabular cup positioning. However, it may be associated with a high reoperation rate, and the fu...

  • Commentary
  • Open Access
4 Citations
3,104 Views
6 Pages

18 August 2022

Smoking is a common health risk behavior that has substantial effects on perioperative risk and postoperative surgical outcomes. Current smoking is clearly linked to an increased risk of perioperative cardiovascular, pulmonary and wound healing compl...

  • Article
  • Open Access
3 Citations
3,622 Views
14 Pages

Palbociclib Induces the Apoptosis of Lung Squamous Cell Carcinoma Cells via RB-Independent STAT3 Phosphorylation

  • Wenjing Xiang,
  • Wanchen Qi,
  • Huayu Li,
  • Jia Sun,
  • Chao Dong,
  • Haojie Ou and
  • Bing Liu

18 August 2022

Lung squamous cell carcinoma (LUSC) treatment response is poor and treatment alternatives are limited. Palbociclib, a cyclin-dependent kinase (CDK) 4/6 inhibitor, has recently been approved for hormone receptor-positive breast cancer patients and app...

  • Article
  • Open Access
7 Citations
3,277 Views
9 Pages

Prognostic Factors of Survival for High-Grade Neuroendocrine Neoplasia of the Bladder: A SEER Database Analysis

  • Veronica Mollica,
  • Francesco Massari,
  • Elisa Andrini,
  • Matteo Rosellini,
  • Andrea Marchetti,
  • Giacomo Nuvola,
  • Elisa Tassinari,
  • Giuseppe Lamberti and
  • Davide Campana

18 August 2022

Background: High-grade neuroendocrine carcinoma (NEC) is a rare and aggressive variant of bladder cancer. Considering its rarity, its therapeutic management is challenging and not standardized. Methods: We analyzed data extracted from the Surveillanc...

  • Article
  • Open Access
7 Citations
3,715 Views
13 Pages

17 August 2022

The targeted therapy with tyrosine kinase inhibitors (TKIs) against the epidermal growth factor receptor mutation (EGFRm) in advanced non-small cell lung cancer (NSCLC) changed the treatment paradigm. REFLECT study (NCT04031898) explored EGFR/T790M t...

  • Article
  • Open Access
5 Citations
2,372 Views
10 Pages

17 August 2022

The personality trait of neuroticism is associated with adverse health outcomes after cancer treatment, but few studies concern men treated for prostate cancer. We examined men with high and low neuroticism treated with radical prostatectomy for cura...

  • Review
  • Open Access
15 Citations
5,745 Views
13 Pages

16 August 2022

Breast cancer continues to be the most diagnosed cancer among women worldwide. Neoadjuvant chemotherapy is the standard of care for breast cancer patients with locally advanced disease and patients with poor pathological features, such as triple-nega...

  • Article
  • Open Access
4 Citations
2,444 Views
10 Pages

16 August 2022

(1) Background: The reasons for changes in the inflammatory markers of patients with surgically resected hepatocellular carcinoma are unclear. We aimed to investigate the association of an inflammatory status with the prognosis of patients with hepat...

  • Perspective
  • Open Access
8 Citations
3,448 Views
8 Pages

Value-Based Care in Systemic Therapy: The Way Forward

  • Aju Mathew,
  • Steve Joseph Benny,
  • Jeffrey Mathew Boby and
  • Bhawna Sirohi

16 August 2022

The rising cost of cancer care has shed light on an important aspect of healthcare delivery. Financial toxicity of therapy must be considered in clinical practice and policy-making. One way to mitigate the impact of financial toxicity of cancer care...

  • Review
  • Open Access
14 Citations
5,326 Views
18 Pages

Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments

  • Dario Trapani,
  • Kiu Tay-Teo,
  • Megan E. Tesch,
  • Felipe Roitberg,
  • Manju Sengar,
  • Sara C. Altuna,
  • Michael J. Hassett,
  • Armando A. Genazzani,
  • Aaron S. Kesselheim and
  • Giuseppe Curigliano

16 August 2022

Background: Advances in cancer medicines have resulted in tangible health impacts, but the magnitude of benefits of approved cancer medicines could vary greatly. Health Technology Assessment (HTA) is a multidisciplinary process used to inform resourc...

  • Systematic Review
  • Open Access
1 Citations
3,827 Views
11 Pages

Is There a Survival Benefit of Adjuvant Chemotherapy in Stage IC1 Epithelial Ovarian Cancer Patients? A Meta-Analysis

  • Vasilios Pergialiotis,
  • Efstathia Liatsou,
  • Aggeliki Rouvali,
  • Dimitrios Haidopoulos,
  • Dimitrios Efthymios,
  • Michalis Liontos,
  • Alexandros Rodolakis and
  • Nikolaos Thomakos

15 August 2022

The purpose of the present systematic review is to clarify whether adjuvant chemotherapy improves survival rates in women with stage IC1 ovarian cancer. We searched Medline, Scopus, Clinicaltrials.gov, EMBASE, Cochrane Central Register of Controlled...

  • Article
  • Open Access
8 Citations
3,563 Views
15 Pages

The Use of Assisted Reproductive Technology by European Childhood Cancer Survivors

  • Anja Borgmann-Staudt,
  • Simon Michael,
  • Greta Sommerhaeuser,
  • Marta-Julia Fernández-González,
  • Lucía Alacán Friedrich,
  • Stephanie Klco-Brosius,
  • Tomas Kepak,
  • Jarmila Kruseova,
  • Gisela Michel and
  • Magdalena Balcerek
  • + 3 authors

15 August 2022

CCS often wish to have biological children yet harbour concerns about fertility impairment, pregnancy risks and the general health risks of prospective offspring. To clarify these concerns, health outcomes in survivor offspring born following ART (n...

  • Article
  • Open Access
20 Citations
4,992 Views
17 Pages

15 August 2022

Background: This study aims to evaluate the overall and breast cancer-specific survival (BCSS) after breast-conserving surgery (BCS) plus radiotherapy (RT) compared with mastectomy plus RT in resectable breast cancer. Moreover, the aim is to also ide...

  • Article
  • Open Access
1 Citations
2,988 Views
16 Pages

Detection of Potential Mutated Genes Associated with Common Immunotherapy Biomarkers in Non-Small-Cell Lung Cancer Patients

  • Lei Cao,
  • Zhili Cao,
  • Hongsheng Liu,
  • Naixin Liang,
  • Zhongxing Bing,
  • Caijuan Tian and
  • Shanqing Li

15 August 2022

Microsatellite instability (MSI), high tumor mutation burden (TMB-H) and programmed cell death 1 ligand 1 (PD-L1) expression are hot biomarkers related to the improvement of immunotherapy response. Two cohorts of non-small-cell lung cancer (NSCLC) we...

  • Article
  • Open Access
7 Citations
3,649 Views
13 Pages

Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study

  • Federica Bernardini,
  • Gabriella Ferrandina,
  • Caterina Ricci,
  • Anna Fagotti,
  • Francesco Fanfani,
  • Anna Franca Cavaliere,
  • Benedetta Gui,
  • Giovanni Scambia and
  • Rosa De Vincenzo

14 August 2022

Background: To date, little and discordant data still exists on the management of cervical cancer (CC) during pregnancy. In this paper, we report our experience of the treatment of these patients analyzing the oncologic, obstetric, and neonatal outco...

  • Article
  • Open Access
10 Citations
3,255 Views
16 Pages

Donor-Site Morbidity and Quality of Life after Autologous Breast Reconstruction with PAP versus TMG Flap

  • Angela Augustin,
  • Petra Pülzl,
  • Evi M. Morandi,
  • Selina Winkelmann,
  • Ines Schoberleitner,
  • Christine Brunner,
  • Magdalena Ritter,
  • Thomas Bauer,
  • Tanja Wachter and
  • Dolores Wolfram

11 August 2022

The transverse myocutaneous gracilis (TMG) and the profunda artery perforator (PAP) flap are both safe choices for autologous breast reconstruction originating from the same donor region in the upper thigh. We aimed to compare the post-operative outc...

  • Review
  • Open Access
5 Citations
6,466 Views
18 Pages

11 August 2022

Columnar cell lesions (CCLs) of the breast comprise a spectrum of morphologic alterations of the terminal duct lobular unit involving variably dilated and enlarged acini lined by columnar epithelial cells. The World Health Organization currently clas...

  • Article
  • Open Access
10 Citations
3,047 Views
9 Pages

11 August 2022

Background: The present study was conducted to define the lymphedema rate at our institution in patients undergoing axillary (ALND) or inguinal (ILND) lymph node dissection (LND) for melanoma. It aimed to examine risk factors predisposing patients to...

  • Commentary
  • Open Access
10 Citations
4,626 Views
11 Pages

9 August 2022

Quality medical practice is based on science and evidence. For over a half-century, the efficacy of breast cancer screening has been challenged, particularly for women aged 40–49. As each false claim has been raised, it has been addressed and r...

  • Article
  • Open Access
16 Citations
14,402 Views
17 Pages

The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59

  • Anna N. Wilkinson,
  • Jean-Michel Billette,
  • Larry F. Ellison,
  • Michael A. Killip,
  • Nayaar Islam and
  • Jean M. Seely

9 August 2022

The relationship between Canadian mammography screening practices for women 40–49 and breast cancer (BC) stage at diagnosis in women 40–49 and 50–59 years was assessed using data from the Canadian Cancer Registry, provincial/territo...

  • Commentary
  • Open Access
3 Citations
2,944 Views
11 Pages

Engaging Patients in the Canadian Real-World Evidence for Value in Cancer Drugs (CanREValue) Initiative: Processes and Lessons Learned

  • William K. Evans,
  • Pam Takhar,
  • Valerie McDonald,
  • Martine Elias,
  • Louise Binder,
  • Stéphanie Michaud,
  • Mina Tadrous,
  • Caroline Muñoz and
  • Kelvin K. W. Chan

7 August 2022

The Canadian Real-world Evidence for Value in Cancer Drugs (CanREValue) Collaboration established the Engagement Working Group (WG) to ensure that all key stakeholders had an opportunity to provide input into the development and implementation of the...

  • Article
  • Open Access
3,133 Views
12 Pages

6 August 2022

In Switzerland, physicians do not have national guidelines for metastatic colorectal cancer (mCRC) patient care and utilize international versions for management recommendations. Moreover, information about adherence to these guidelines and real-worl...

  • Article
  • Open Access
7 Citations
3,651 Views
19 Pages

Immune Biomarkers in Blood from Sarcoma Patients: A Pilot Study

  • Sarmini Munisamy,
  • Ammu Kutty Radhakrishnan,
  • Premdass Ramdas,
  • Priscilla Josephine Samuel and
  • Vivek Ajit Singh

5 August 2022

The main role of the host immune system is to identify and eliminate cancer cells, which is a complex process, but it is not a fail-safe mechanism. Many sarcoma patients succumb to this disease despite treatments rendered. The aim of this pilot study...

  • Commentary
  • Open Access
1 Citations
3,033 Views
6 Pages

4 August 2022

Pediatric oncologists have the privilege of caring for children and families facing serious, often life-threatening, illnesses. Providing this care is emotionally demanding and associated with significant risks of stress and burnout for oncologists....

  • Article
  • Open Access
40 Citations
5,583 Views
13 Pages

Satisfaction with Telemedicine for Cancer Pain Management: A Model of Care and Cross-Sectional Patient Satisfaction Study

  • Marco Cascella,
  • Sergio Coluccia,
  • Mariacinzia Grizzuti,
  • Maria Cristina Romano,
  • Gennaro Esposito,
  • Anna Crispo and
  • Arturo Cuomo

4 August 2022

Background: Since cancer pain requires complex modalities of care, the proper strategy for addressing its telemedicine-based management should be better defined. This study aimed to trace a pathway for a progressive implementation of the telemedicine...

  • Article
  • Open Access
35 Citations
4,773 Views
16 Pages

Somatostatin Receptor Theranostics for Refractory Meningiomas

  • Betty Salgues,
  • Thomas Graillon,
  • Tatiana Horowitz,
  • Olivier Chinot,
  • Laetitia Padovani,
  • David Taïeb and
  • Eric Guedj

4 August 2022

Somatostatin receptor (SSTR)-targeted peptide receptor radionuclide therapy (PRRT) represents a promising approach for treatment-refractory meningiomas progressing after surgery and radiotherapy. The aim of this study was to provide outcomes of patie...

  • Article
  • Open Access
13 Citations
4,461 Views
19 Pages

4 August 2022

Deregulation of the DNA mismatch repair (MMR) mechanism has been linked to poor prognosis of upper aerodigestive tract cancers. Our recent in vitro data have provided evidence of crosstalk between deregulated miRNAs and MMR genes, caused by tobacco s...

  • Systematic Review
  • Open Access
8 Citations
6,822 Views
14 Pages

Role of Polygenic Risk Score in Cancer Precision Medicine of Non-European Populations: A Systematic Review

  • Howard Lopes Ribeiro Junior,
  • Lázaro Antônio Campanha Novaes,
  • José Guilherme Datorre,
  • Daniel Antunes Moreno and
  • Rui Manuel Reis

4 August 2022

The development of new screening methods and diagnostic tests for traits, common diseases, and cancer is linked to the advent of precision genomic medicine, in which health care is individually adjusted based on a person’s lifestyle, environmen...

  • Article
  • Open Access
5 Citations
3,267 Views
9 Pages

Reducing Unnecessary Biopsies Using Digital Breast Tomosynthesis and Ultrasound in Dense and Nondense Breasts

  • Ibrahim Hadadi,
  • Jillian Clarke,
  • William Rae,
  • Mark McEntee,
  • Wendy Vincent and
  • Ernest Ekpo

4 August 2022

Aim: To compare digital breast tomosynthesis (DBT) and ultrasound in women recalled for assessment after a positive screening mammogram and assess the potential for each of these tools to reduce unnecessary biopsies. Methods: This data linkage study...

  • Review
  • Open Access
48 Citations
7,643 Views
19 Pages

Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond

  • Maple Ye Feng,
  • Landon L. Chan and
  • Stephen Lam Chan

4 August 2022

Hepatocellular carcinoma (HCC) has high mortality. The option of systemic therapy has increased significantly over the past five years. Sorafenib was the first multikinase inhibitor, introduced in 2007, as a treatment option for HCC, and it was the o...

  • Case Report
  • Open Access
11 Citations
3,380 Views
14 Pages

The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature

  • Hana Studentova,
  • Nikol Rusarova,
  • Andrea Ondruskova,
  • Anezka Zemankova,
  • Vladimir Student,
  • Daniela Skanderova and
  • Bohuslav Melichar

3 August 2022

Background: Renal cell carcinoma with sarcomatoid dedifferentiation represents a rare histological entity characterized by aggressive behavior, limited efficacy of tyrosine kinase inhibitors or mTOR inhibitors, and poor outcome. The immune checkpoint...

  • Article
  • Open Access
5 Citations
2,811 Views
9 Pages

Clinical Lymph Node Involvement as a Predictor for Cancer-Specific Survival in Patients with Penile Squamous Cell Cancer

  • Makoto Kawase,
  • Kimiaki Takagi,
  • Kei Kawada,
  • Takashi Ishida,
  • Masayuki Tomioka,
  • Torai Enomoto,
  • Shota Fujimoto,
  • Tomoki Taniguchi,
  • Hiroki Ito and
  • Takuya Koie
  • + 7 authors

1 August 2022

We aimed to identify prognostic predictive factors of patients with penile squamous cell carcinoma (PSCC). This retrospective study reviewed the clinical and pathological data of patients with PSCC at 10 institutions in Japan between January 2008 and...

  • Communication
  • Open Access
6 Citations
3,040 Views
9 Pages

Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease

  • Gian Paolo Caviglia,
  • Aurora Nicolosi,
  • Maria Lorena Abate,
  • Patrizia Carucci,
  • Chiara Rosso,
  • Emanuela Rolle,
  • Angelo Armandi,
  • Serena Aneli,
  • Antonella Olivero and
  • Elisabetta Bugianesi
  • + 5 authors

31 July 2022

Reliable non-invasive biomarkers for the surveillance of patients at risk of hepatocellular carcinoma (HCC) development represent an unmet medical need. Recently, the liver-cancer-specific isoform of serine protease inhibitor Kazal (LC-SPIK) has been...

  • Article
  • Open Access
12 Citations
4,571 Views
15 Pages

Integrative Multi-Omics Analysis for the Determination of Non-Muscle Invasive vs. Muscle Invasive Bladder Cancer: A Pilot Study

  • Evan Yi-Wen Yu,
  • Hao Zhang,
  • Yuanqing Fu,
  • Ya-Ting Chen,
  • Qiu-Yi Tang,
  • Yu-Xiang Liu,
  • Yan-Xi Zhang,
  • Shi-Zhi Wang,
  • Anke Wesselius and
  • Bin Xu
  • + 2 authors

31 July 2022

Objectives: The molecular landscape of non-muscle-invasive (NMIBC) and muscle-invasive (MIBC) bladder cancer based on molecular characteristics is essential but poorly understood. In this pilot study we aimed to identify a multi-omics signature that...

  • Review
  • Open Access
17 Citations
8,344 Views
16 Pages

Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma

  • Luisa M. Cardenas,
  • Jasna E. Deluce,
  • Shahrukh Khan,
  • Omar Gulam,
  • Saman Maleki Vareki,
  • Ricardo Fernandes and
  • Aly-Khan A. Lalani

30 July 2022

While surgical resection has remained the mainstay of treatment in early-stage renal cell carcinoma (RCC), therapeutic options in the advanced setting have remarkably expanded over the last 20 years. Tyrosine kinase inhibitors targeting the vascular...

  • Article
  • Open Access
31 Citations
4,388 Views
19 Pages

Recruiting Adolescent and Young Adult Cancer Survivors for Patient-Reported Outcome Research: Experiences and Sample Characteristics of the SURVAYA Study

  • Carla Vlooswijk,
  • Lonneke V. van de Poll-Franse,
  • Silvie H. M. Janssen,
  • Esther Derksen,
  • Milou J. P. Reuvers,
  • Rhodé Bijlsma,
  • Suzanne E. J. Kaal,
  • Jan Martijn Kerst,
  • Jacqueline M. Tromp and
  • Olga Husson
  • + 6 authors

29 July 2022

Background: Participation of Adolescents and Young Adults with cancer (AYAs: 18–39 years at time of diagnosis) in patient-reported outcome studies is warranted given the limited knowledge of (long-term) physical and psychosocial health outcomes...

  • Feature Paper
  • Review
  • Open Access
44 Citations
4,978 Views
24 Pages

Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma

  • Qian Zhang,
  • Hanlin Li,
  • Yang Liu,
  • Jian Li,
  • Chunling Wu and
  • Hua Tang

29 July 2022

Exosomes, extracellular vesicles with a diameter of 40 to 160 nm, are among the smallest extracellular vesicles released by cells. They deliver different cargoes, including proteins, DNAs, and RNAs, and facilitate communication between cells to coord...

  • Article
  • Open Access
8 Citations
3,923 Views
13 Pages

Combined Exoscopic and Endoscopic Two-Step Keyhole Approach for Intracranial Meningiomas

  • Tadashi Watanabe,
  • Kenichiro Iwami,
  • Yugo Kishida,
  • Tetsuya Nagatani,
  • Hiroshi Yatsuya and
  • Shigeru Miyachi

29 July 2022

The advantages of neuroendoscopic surgery are the wide viewing angle and the freedom of an axis of view with minimal surgical trauma. With the advent of the exoscope, which has similar advantages to endoscopy, such as a small body and ergonomically s...

  • Comment
  • Open Access
2,063 Views
2 Pages

29 July 2022

Lesack et al. recently published a cross-sectional study that focused on human papillomavirus (HPV) self-sampling in the screened population, a population not conventionally thought of for HPV self-sampling. They found 52% of well-screened, highly ed...

  • Article
  • Open Access
9 Citations
3,989 Views
30 Pages

Identifying Breast Cancer Recurrence in Administrative Data: Algorithm Development and Validation

  • Claire M. B. Holloway,
  • Omid Shabestari,
  • Maria Eberg,
  • Katharina Forster,
  • Paula Murray,
  • Bo Green,
  • Ali Vahit Esensoy,
  • Andrea Eisen and
  • Jonathan Sussman

28 July 2022

Breast cancer recurrence is an important outcome for patients and healthcare systems, but it is not routinely reported in cancer registries. We developed an algorithm to identify patients who experienced recurrence or a second case of primary breast...

  • Article
  • Open Access
22 Citations
5,155 Views
14 Pages

Treatment of Basal Cell Carcinoma with Electrochemotherapy: Insights from the InspECT Registry (2008–2019)

  • Giulia Bertino,
  • Tobian Muir,
  • Joy Odili,
  • Ales Groselj,
  • Roberto Marconato,
  • Pietro Curatolo,
  • Erika Kis,
  • Camilla Kjaer Lonkvist,
  • James Clover and
  • the InspECT BCC Working Group
  • + 6 authors

28 July 2022

This prospective registry-based study aims to describe electrochemotherapy (ECT) modalities in basal cell carcinoma (BCC) patients and evaluate its efficacy, safety, and predictive factors. The International Network for Sharing Practices of Electroch...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729